000 | 01897 a2200517 4500 | ||
---|---|---|---|
005 | 20250513125527.0 | ||
264 | 0 | _c19971125 | |
008 | 199711s 0 0 eng d | ||
022 | _a1058-4838 | ||
024 | 7 |
_a10.1086/513766 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aShlaes, D M | |
245 | 0 | 0 |
_aSociety for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. _h[electronic resource] |
260 |
_bClinical infectious diseases : an official publication of the Infectious Diseases Society of America _cSep 1997 |
||
300 |
_a584-99 p. _bdigital |
||
500 | _aPublication Type: Guideline; Journal Article; Practice Guideline; Review | ||
650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
650 | 0 | 4 |
_aBacteria _xdrug effects |
650 | 0 | 4 |
_aBacterial Infections _xdrug therapy |
650 | 0 | 4 |
_aCross Infection _xmicrobiology |
650 | 0 | 4 |
_aDrug Resistance, Microbial _xgenetics |
650 | 0 | 4 | _aHospitalization |
650 | 0 | 4 | _aHospitals |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aPatient Isolation |
650 | 0 | 4 | _aSocieties, Medical |
650 | 0 | 4 | _aUnited States |
650 | 0 | 4 | _aVirulence |
700 | 1 | _aGerding, D N | |
700 | 1 | _aJohn, J F | |
700 | 1 | _aCraig, W A | |
700 | 1 | _aBornstein, D L | |
700 | 1 | _aDuncan, R A | |
700 | 1 | _aEckman, M R | |
700 | 1 | _aFarrer, W E | |
700 | 1 | _aGreene, W H | |
700 | 1 | _aLorian, V | |
700 | 1 | _aLevy, S | |
700 | 1 | _aMcGowan, J E | |
700 | 1 | _aPaul, S M | |
700 | 1 | _aRuskin, J | |
700 | 1 | _aTenover, F C | |
700 | 1 | _aWatanakunakorn, C | |
773 | 0 |
_tClinical infectious diseases : an official publication of the Infectious Diseases Society of America _gvol. 25 _gno. 3 _gp. 584-99 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1086/513766 _zAvailable from publisher's website |
999 |
_c9291856 _d9291856 |